Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ASCO® DIRECT Highlights 2019: Lung Cancer Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 30 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene Corporation, Daiichi …
Explore this list of curated, nationally available materials to support patients receiving oral therapies for HR+, HER2- breast cancer. The resources include clinical guidelines, resources for the multidisciplinary cancer care team, patient education resources and more. Want to recommend another resource? Please email the provider education department. Clinical Guidelines National Comprehensive …
References NCCN Guidelines for Patients. Breast Cancer Metastatic, 2022. Accessed May 4, 2022. https://www.nccn.org/patients/guidelines/content/PDF/stage_iv_breast-patient.pdf NCI Breast Cancer Treatment (Adult) (PDQ®)–Patient Version. Accessed May 26, 2022. https://www.cancer.gov/types/breast/patient/breast-treatment-pdq NCCN Clinical Practice Guidelines in Oncology. Breast …
Key resources for healthcare professionals leading care for myeloma patients.
Care Coordination: The Role of Pharmacy to Help Manage Patients with Cancer on Oral Oncolytics Resource List With the guidance of its Advisory Committee and Partner Organizations, ACCC has developed a curated resource library that incorporates publications, tools, and other assets that can help care team members navigate the complex issue of coordinating care when dispensing oral oncolytics. Provider …
ASCO® DIRECT Highlights 2019: Cancer Genomics and Molecular Diagnostics Target Audience The primary target audience for this meeting comprise the multidisciplinary clinical cancer care team members including, but not limited to medical, surgical, and radiation oncologists; fellows; gastroenterologists; nephrologists; neurologists; pathologists; pulmonologists; radiologists; researchers; oncology …
The following links provide resources to help providers educate their patients about clinical trials and find financial assistance programs. American Cancer Society This site contains factsheets, videos, worksheets, and other resources and tools for both clinicians and patients. National Cancer Institute Through the publications locator, NCI provides numerous fact sheets, …
Recent advances in immuno-oncology (IO) therapies have been rewarded by rapid, durable responses for subsets of patients in many cancers that have been resistant to conventional treatments. Just as with developments with chemotherapy and targeted therapies, increasing numbers of IO patients with metastatic disease are transitioning into post-treatment survivorship. However, these patients may experience …
ASCO® DIRECT Highlights 2019: Multiple Myeloma Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 45 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene Corporation, Daiichi …
Monitoring a patient’s measurable residual disease (MRD) at various points throughout active treatment and into remission provides important personalized insights into the effectiveness of a given therapy and may be used to predict which patients are at risk of relapse. Testing for MRD can shape treatment choices and overall patient management to achieve better outcomes. The Association of Community …
Clara Lambert is an active member of the Academy of Oncology Nurse & Patient Navigators (AONN+). She participates in the Conference Planning, Policy and Advocacy (co-chair of Advocacy), and Technology Committees, as well as speaking on financial navigation and other topics. She is also the director of financial navigation at TailorMed. Previously, she spent seven years as a financial navigator …
Our Partner Our Supporter
Optimizing Outcomes for Patients with Urothelial Carcinoma This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Genentech, Astellas and Seattle Genetics, Inc. Target audience The target audience for this initiative includes medical …
Multiple myeloma, also known as myeloma, is the third most common hematologic cancer (cancer of the blood). However, compared to more frequently occurring cancers (e.g., breast, prostate, lung, and colorectal cancers), multiple myeloma is relative rare and accounts for only 1.6 percent of diagnoses each year. For 2018, the American Cancer Society estimates that 30,770 new cases of myeloma will be diagnosed …
Overexpression or amplification of the human epidermal growth factor receptor 2 (HER2) is present in approximately 15 percent to 20 percent of patients with metastatic breast cancer. First-line therapy with anti-HER2 targeted agents have significantly improved outcomes for patients with HER2-positive breast cancer. Nevertheless, most of these patients eventually relapse. Several novel therapies have …
At the conclusion of the Best Practices for Implementing Cancer Immunotherapy in the Community education initiative participants should be able to: Evaluate practical issues related to immunotherapy and devise strategies to over the barriers to providing optimal patient care in the community setting. Assess alignment of current practice with best practices related to coordination and …
The main goal of this project is to raise awareness about provider education needs related to the multiple myeloma patient population.
Educational Materials Blood and Marrow Transplant Clinical Social Worker Role Description NCCN: Guidelines for treatment of ALL (log in required) NCCN: Acute Lymphoblastic Leukemia Patient Guidelines The Leukemia & Lymphoma Society (LLS) Materials Guides, Booklets & Webcasts: LLS Acute Lymphoblastic Leukemia For patients, an interactive information hub …
ASCO® DIRECT Highlights 2019: Healthcare Delivery and Survivorship Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 30 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, …
Survivorship in the Era of Immuno-Oncology As more patients are treated with immunotherapies for cancer, increasing numbers of patients with metastatic disease are transitioning in survivorship. Patients who respond to immuno-oncology therapy may be exposed to treatment for months or even years. Thus, the survivorship experience for many patients with metastatic disease has changed significantly due …